Sg Americas Securities, LLC Alkermes Plc. Transaction History

Sg Americas Securities, LLC

  • $30.5 Billion
  • Q1 2025

A detailed history of Sg Americas Securities, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 13,988 shares of ALKS stock, worth $377,676. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,988
Previous 11,116 25.84%
Holding current value
$377,676
Previous $320,000 44.38%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 15, 2025
BUY
$28.08 - $36.0 $80,645 - $103,392
2,872 Added 25.84%
13,988 $462,000
Q4 2024

Jan 17, 2025
SELL
$25.7 - $31.46 $238,573 - $292,043
-9,283 Reduced 45.51%
11,116 $320,000
Q3 2024

Oct 03, 2024
BUY
$23.01 - $28.55 $469,380 - $582,391
20,399 New
20,399 $571,000
Q1 2024

May 06, 2024
SELL
$26.4 - $32.56 $432,643 - $533,593
-16,388 Reduced 38.73%
25,921 $702,000
Q4 2023

Jan 12, 2024
SELL
$23.37 - $28.68 $2.28 Million - $2.8 Million
-97,624 Reduced 69.76%
42,309 $1.17 Million
Q3 2023

Oct 13, 2023
BUY
$27.17 - $31.97 $3.7 Million - $4.35 Million
136,214 Added 3662.65%
139,933 $3.92 Million
Q2 2023

Jul 10, 2023
SELL
$28.34 - $33.63 $2.33 Million - $2.77 Million
-82,376 Reduced 95.68%
3,719 $116,000
Q1 2023

Apr 28, 2023
BUY
$25.31 - $29.02 $1.8 Million - $2.06 Million
70,993 Added 470.09%
86,095 $2.43 Million
Q4 2022

Feb 02, 2023
SELL
$21.94 - $26.24 $164,901 - $197,219
-7,516 Reduced 33.23%
15,102 $395,000
Q3 2022

Oct 31, 2022
BUY
$22.0 - $31.87 $145,684 - $211,043
6,622 Added 41.4%
22,618 $505,000
Q2 2022

Jul 29, 2022
SELL
$26.4 - $30.54 $1.32 Million - $1.52 Million
-49,925 Reduced 75.73%
15,996 $477,000
Q1 2022

Apr 29, 2022
BUY
$23.07 - $27.99 $65,403 - $79,351
2,835 Added 4.49%
65,921 $1.73 Million
Q4 2021

Feb 07, 2022
BUY
$21.47 - $32.08 $473,585 - $707,620
22,058 Added 53.76%
63,086 $1.47 Million
Q3 2021

Nov 01, 2021
SELL
$23.37 - $32.13 $840,899 - $1.16 Million
-35,982 Reduced 46.72%
41,028 $1.27 Million
Q2 2021

Aug 12, 2021
BUY
$18.78 - $25.15 $1.08 Million - $1.45 Million
57,744 Added 299.72%
77,010 $1.89 Million
Q1 2021

May 13, 2021
BUY
$18.21 - $23.2 $202,203 - $257,612
11,104 Added 136.05%
19,266 $360,000
Q4 2020

Feb 04, 2021
SELL
$15.39 - $22.1 $1.55 Million - $2.23 Million
-100,965 Reduced 92.52%
8,162 $163,000
Q3 2020

Nov 09, 2020
BUY
$16.16 - $20.66 $1.76 Million - $2.25 Million
109,127 New
109,127 $1.81 Million
Q2 2020

Jul 20, 2020
SELL
$13.31 - $19.41 $113,813 - $165,974
-8,551 Closed
0 $0
Q1 2020

Apr 30, 2020
BUY
$13.06 - $21.24 $44,103 - $71,727
3,377 Added 65.27%
8,551 $123,000
Q4 2019

Jan 28, 2020
SELL
$17.29 - $21.74 $339,679 - $427,104
-19,646 Reduced 79.15%
5,174 $106,000
Q3 2019

Nov 04, 2019
SELL
$19.51 - $24.28 $10,554 - $13,135
-541 Reduced 2.13%
24,820 $484,000
Q2 2019

Jul 29, 2019
SELL
$21.47 - $37.33 $1.65 Million - $2.86 Million
-76,621 Reduced 75.13%
25,361 $572,000
Q1 2019

Apr 29, 2019
BUY
$28.4 - $36.49 $2.56 Million - $3.29 Million
90,066 Added 755.84%
101,982 $3.72 Million
Q4 2018

Feb 01, 2019
SELL
$27.94 - $44.61 $276,550 - $441,549
-9,898 Reduced 45.37%
11,916 $352,000
Q3 2018

Nov 06, 2018
BUY
$38.6 - $46.12 $739,691 - $883,797
19,163 Added 722.86%
21,814 $926,000
Q2 2018

Aug 07, 2018
SELL
$40.56 - $51.36 $112,756 - $142,780
-2,780 Reduced 51.19%
2,651 $109,000
Q1 2018

May 03, 2018
BUY
$53.61 - $67.26 $179,325 - $224,984
3,345 Added 160.35%
5,431 $315,000
Q4 2017

Jan 24, 2018
BUY
$47.69 - $55.39 $99,481 - $115,543
2,086
2,086 $114,000

Others Institutions Holding ALKS

# of Institutions
402
Shares Held
176M
Call Options Held
229K
Put Options Held
436K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.43B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email